Literature DB >> 20490590

Analysis on the infection among patients with nephrotic syndromes and systemic vasculitis treated with mycophenolate mofetil.

Feng Wang, Niansong Wang, Junhui Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20490590     DOI： 10.1007/s10067-010-1482-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  14 in total

1.  CMV in kidney transplants in the tacrolimus-mycophenolate era.

Authors:  J F Cailhier; A Boucher; C Béliveau; L Poirier; J Delorme; K Weiss; M Laverdière; M J Hébert; V Pichette; R Dandavino
Journal:  Transplant Proc       Date:  2001 Feb-Mar       Impact factor: 1.066

2.  New mechanisms of action of mycophenolate mofetil in transplant recipients by assessment of its pharmacodynamics.

Authors:  M J Barten; T van Gelder; J F Gummert; R Shorthouse; K Boeke; M E Billingham; R E Morris
Journal:  Transplant Proc       Date:  2001-05       Impact factor: 1.066

Review 3.  Mycophenolate mofetil in chronic glomerular diseases.

Authors:  H Oliveira Sá; T Mendes
Journal:  Nefrologia       Date:  2008       Impact factor: 2.033

Review 4.  Mycophenolate mofetil.

Authors:  Amar Surjushe; D G Saple
Journal:  Indian J Dermatol Venereol Leprol       Date:  2008 Mar-Apr       Impact factor: 2.545

5.  Mycophenolate mofetil; a review of indications and use in a large tertiary hospital.

Authors:  Nimeshan Geevasinga; Lucinda Wallman; Constance H Katelaris
Journal:  Iran J Allergy Asthma Immunol       Date:  2005-12       Impact factor: 1.464

6.  Is mycophenolate mofetil less safe than azathioprine in elderly renal transplant recipients?

Authors:  David W Johnson; David L Nicol; David M Purdie; John M Preston; Allison M Brown; Carmel M Hawley; Scott B Campbell; Darryl Wall; Anthony D Griffin; Nicole M Isbel
Journal:  Transplantation       Date:  2002-04-15       Impact factor: 4.939

7.  Pharmacodynamic monitoring of the conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in stable kidney-allograft recipients.

Authors:  Torsten Böhler; Cindy Canivet; Sylvain Galvani; Nicole Therville; Robert Salvayre; Anne Negre-Salvayre; Dominique Durand; Mogens Thomsen; Lionel Rostaing; Nassim Kamar
Journal:  Int Immunopharmacol       Date:  2008-02-20       Impact factor: 4.932

Review 8.  Mycophenolates in transplantation.

Authors:  Hans W Sollinger
Journal:  Clin Transplant       Date:  2004-10       Impact factor: 2.863

9.  Idiopathic membranous nephropathy: diagnosis and treatment.

Authors:  Fernando C Fervenza; Sanjeev Sethi; Ulrich Specks
Journal:  Clin J Am Soc Nephrol       Date:  2008-01-30       Impact factor: 8.237

Review 10.  Pharmacokinetics of mycophenolate mofetil and sirolimus in children.

Authors:  Guido Filler; Jamie Bendrick-Peart; Uwe Christians
Journal:  Ther Drug Monit       Date:  2008-04       Impact factor: 3.681
View more
  2 in total

1.  Effect of mycophenolate mofetil on the white blood cell count and the frequency of infection in systemic lupus erythematosus.

Authors:  Ananta Subedi; Laurence S Magder; Michelle Petri
Journal:  Rheumatol Int       Date:  2015-04-03       Impact factor: 2.631

Review 2.  Primary Cutaneous Nocardiosis in a Patient With Nephrotic Syndrome: A Case Report and Review of the Literature.

Authors:  Bing Chen; Jin Tang; Zeyuan Lu; Niansong Wang; Xuping Gao; Feng Wang
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.